Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release
Yue Ma, Risheka Ratnasabapathy, Ivan De Backer, Chioma Izzi-Engbeaya, Marie-Sophie Nguyen-Tu, Joyceline Cuenco, Ben Jones, Christopher D. John, Brian Y.H. Lam, Guy A. Rutter, Giles S.H. Yeo, Waljit S. Dhillo, James Gardiner
Yue Ma, Risheka Ratnasabapathy, Ivan De Backer, Chioma Izzi-Engbeaya, Marie-Sophie Nguyen-Tu, Joyceline Cuenco, Ben Jones, Christopher D. John, Brian Y.H. Lam, Guy A. Rutter, Giles S.H. Yeo, Waljit S. Dhillo, James Gardiner
View: Text | PDF
Research Article Endocrinology Neuroscience

Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release

  • Text
  • PDF
Abstract

Glucokinase (GK) is highly expressed in the hypothalamic paraventricular nucleus (PVN); however, its role is currently unknown. We found that GK in the PVN acts as part of a glucose-sensing mechanism within the PVN that regulates glucose homeostasis by controlling glucagon-like peptide 1 (GLP-1) release. GLP-1 is released from enteroendocrine L cells in response to oral glucose. Here we identify a brain mechanism critical to the release of GLP-1 in response to oral glucose. We show that increasing expression of GK or injection of glucose into the PVN increases GLP-1 release in response to oral glucose. On the contrary, decreasing expression of GK or injection of nonmetabolizable glucose into the PVN prevents GLP-1 release. Our results demonstrate that gluco-sensitive GK neurons in the PVN are critical to the response to oral glucose and subsequent release of GLP-1.

Authors

Yue Ma, Risheka Ratnasabapathy, Ivan De Backer, Chioma Izzi-Engbeaya, Marie-Sophie Nguyen-Tu, Joyceline Cuenco, Ben Jones, Christopher D. John, Brian Y.H. Lam, Guy A. Rutter, Giles S.H. Yeo, Waljit S. Dhillo, James Gardiner

×

Figure 2

Effect of genetically decreased PVN GK activity on oGTT.

Options: View larger image (or click on image) Download as PowerPoint
Effect of genetically decreased PVN GK activity on oGTT.
Groups of adult...
Groups of adult male Wistar rats were injected with either rAAV-GFP (iPVN-GFP) or rAAV-ASGK (iPVN-ASGK) bilaterally into the PVN. They then underwent an oGTT and ITT. (A) GK activity in ARC, VMN, and PVN of iPVN-GFP (green) or iPVN-ASGK (magenta). (B) Plasma glucose during an oGTT in iPVN-GFP and iPVN-ASGK rats. (C) AUC analysis of 0- to 60-minute plasma glucose during an oGTT in iPVN-GFP and iPVN-ASGK rats. (D) Plasma insulin levels during an oGTT in iPVN-GFP and iPVN-ASGK rats. (E) AUC analysis of 0- to 60-minute plasma insulin during an oGTT in iPVN-GFP and iPVN-ASGK rats. (F) Plasma GLP-1 levels during an oGTT in iPVN-GFP and iPVN-ASGK rats. (G) AUC analysis of 0- to 60-minute plasma GLP-1 during an oGTT in iPVN-GFP (triangles) and iPVN-ASGK (squares) rats. (H) Plasma glucose levels during an ITT in iPVN-GFP and iPVN-ASGK rats. Data are represented as mean ± SEM; n = 8. *P < 0.05, **P < 0.01, ***P < 0.001. Data for A were analyzed by 1-way ANOVA and post hoc Holm-Šídák; data for B, D, F, and G were analyzed by 2-way ANOVA and post hoc Holm-Šídák; data for C, E, and H were analyzed by t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts